Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Financing Activities: 2016-2024

Historic Cash from Financing Activities for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $27.6 million.

  • Organogenesis Holdings' Cash from Financing Activities fell 508.65% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 370.87%. This contributed to the annual value of $27.6 million for FY2024, which is 602.03% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Cash from Financing Activities of $27.6 million as of FY2024, which was up 602.03% from -$5.5 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Cash from Financing Activities ranged from a high of $42.5 million in FY2020 and a low of -$5.5 million during FY2023.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$2.2 million (2022), whereas its average is $6.6 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Cash from Financing Activities crashed by 150.34% in 2023, and later soared by 602.03% in 2024.
  • Over the past 5 years, Organogenesis Holdings' Cash from Financing Activities (Yearly) stood at $42.5 million in 2020, then crashed by 102.44% to -$1.0 million in 2021, then plummeted by 112.26% to -$2.2 million in 2022, then plummeted by 150.34% to -$5.5 million in 2023, then soared by 602.03% to $27.6 million in 2024.